Intuitive Surgical reported Q3 revenue of $3.05B (est. $2.91B) and adjusted EPS of $3.00 (est. $2.65). Worldwide procedure growth of 15% beat expectations. However, the company narrowed its full-year da Vinci procedure growth guidance to 14-15% from 13.5-15.5%, and recorded a $450M antitrust settlement charge. Shares dropped over 10% in after-hours trading.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
